NCT02982954 2022-11-01
CHECKMATE 920
Bristol-Myers Squibb
Phase 4 Completed
Clinical Trials
10 trialsNCT02596035 2022-10-27
CheckMate 374
Bristol-Myers Squibb
Phase 4 Completed
NCT00414765 2021-06-08
Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
Novartis
Phase 4 Completed
NCT01206764 2019-06-24
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.
Novartis
Phase 4 Completed
NCT01266837 2017-11-14
MARC-2
iOMEDICO AG
Phase 4 Completed
NCT01521715 2017-08-23
FLIPPER
iOMEDICO AG
Phase 4 Completed
NCT01514448 2017-07-19
Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib
Novartis
Phase 4 Completed
NCT00172003 2016-11-18
Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
Novartis
Phase 4 Completed
NCT00352859 2014-12-30
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Bayer
Phase 4 Terminated
NCT00706706 2013-01-18
MRCC RCC
Pfizer
Phase 4 Completed